A new series of 4-thiazolidinone derivatives (3) have been synthesized and evaluated for in vivo hypoglycemic activity. The synthesized compounds were also-evaluated for in vitro antibacterial activity by cup plate method against Escherichia coli and Bacillus subtilis.